akston biosciences corporation
PrivateLast Round
IPO Announced
Oct 8, 2025
Last Round Size
$5.16M
Total Funding Raised
$36.56M
Company Overview
A pet biotechnology company that develops and commercializes biopharmaceutical products for companion animals.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
akston biosciences corporation Comps
Related companies by embedding similarity.
akston biosciences corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Oct 8, 2025 | ||||
| Venture Round | Apr 15, 2022 | ||||
| Series F | Jun 22, 2021 | ||||
| Series E | Apr 9, 2020 | ||||
| Grant | Jun 25, 2019 | ||||
Convertible Debt | May 10, 2019 |
akston biosciences corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about akston biosciences corporation's valuation, stock price, and market status.